Merck Professional - Search News

News

Merck, Verona Pharma and food and drug administration

Merck buys Raleigh pharma company for $10 billion, drawn by new COPD drug

Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease in more than a decade.

InvestorsHub on MSN · 3d

Merck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug Portfolio

Merck (NYSE:MRK) announced Wednesday it has struck a definitive agreement to acquire Verona Pharma PLC ADR (NASDAQ:VRNA) in a transaction valued at approximately $10 billion, or $107 per American Depositary Share.

Reuters · 2d

Merck shells out $10 billion for Verona in bid to diversify beyond ...

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug ...

18hon MSN

FDA approves shot that protects dogs from fleas and ticks for 8-12 months

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...

1don MSN

Blockbuster long acting flea and tick treatment for dogs coming after FDA approval

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

GEN7y

Merck Manual Professional | Best Science Apps

The Merck Manual – Professional Version is an excellent resource for medical professionals. The app includes an extensive list of medical topics, ranging from clinical pharmacology to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results